Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of functional outcome after symptomatic intracranial hemorrhage complicating intravenous thrombolysis: results from the SITS-ISTR.
Tsivgoulis G, Palaiodimou L, Stefanou MI, Theodorou A, Kõrv J, Nunes AP, Candelaresi P, Dall'Ora E, Sariaslani P, Provinciali L, Conforto AB, Cidrao AAL, Karapanayiotides T, Ahmed N. Tsivgoulis G, et al. Among authors: korv j. Eur J Neurol. 2023 Oct;30(10):3161-3171. doi: 10.1111/ene.15968. Epub 2023 Jul 14. Eur J Neurol. 2023. PMID: 37410547
Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003).
Sandset EC, Murray G, Boysen G, Jatuzis D, Kõrv J, Lüders S, Richter PS, Roine RO, Terént A, Thijs V, Berge E; SCAST Study Group. Sandset EC, et al. Among authors: korv j. Int J Stroke. 2010 Oct;5(5):423-7. doi: 10.1111/j.1747-4949.2010.00473.x. Int J Stroke. 2010. PMID: 20854630 Clinical Trial.
PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke. Rationale and design of a randomised, open, phase III, clinical trial with blinded outcome assessment.
Reinink H, de Jonge JC, Bath PM, van de Beek D, Berge E, Borregaard S, Ciccone A, Csiba L, Demotes J, Dippel DW, Kõrv J, Kurkowska-Jastrzebska I, Lees KR, Macleod MR, Ntaios G, Randall G, Thomalla G, van der Worp HB. Reinink H, et al. Among authors: korv j. Eur Stroke J. 2018 Sep;3(3):291-298. doi: 10.1177/2396987318772687. Epub 2018 Apr 30. Eur Stroke J. 2018. PMID: 30246150 Free PMC article.
Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline.
Klijn CJ, Paciaroni M, Berge E, Korompoki E, Kõrv J, Lal A, Putaala J, Werring DJ. Klijn CJ, et al. Among authors: korv j. Eur Stroke J. 2019 Sep;4(3):198-223. doi: 10.1177/2396987319841187. Epub 2019 Apr 9. Eur Stroke J. 2019. PMID: 31984228 Free PMC article.
Tenecteplase in wake-up ischemic stroke trial: Protocol for a randomized-controlled trial.
Roaldsen MB, Lindekleiv H, Eltoft A, Jusufovic M, Søyland MH, Petersson J, Indredavik B, Tveiten A, Putaala J, Christensen H, Kõrv J, Jatužis D, Engelter ST, Marco De Marchis G, Wilsgaard T, Werring DJ, Robinson T, Mathiesen EB, Berge E. Roaldsen MB, et al. Among authors: korv j. Int J Stroke. 2021 Oct;16(8):990-994. doi: 10.1177/1747493020984073. Epub 2021 Jan 14. Int J Stroke. 2021. PMID: 33446083 Free PMC article.
Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST).
Eltoft A, Wilsgaard T, Roaldsen MB, Søyland MH, Lundström E, Petersson J, Indredavik B, Putaala J, Christensen H, Kõrv J, Jatužis D, Engelter ST, De Marchis GM, Werring DJ, Robinson T, Tveiten A, Mathiesen EB. Eltoft A, et al. Among authors: korv j. Trials. 2022 May 19;23(1):421. doi: 10.1186/s13063-022-06301-0. Trials. 2022. PMID: 35590386 Free PMC article. Clinical Trial.
97 results